HYDROmorphone HCl 6 mg Injectable Syringes Recalled Due to Sterility Assurance Issues
SCA Pharmaceuticals is recalling 1,425 syringes of HYDROmorphone HCl 6 mg/30 mL due to lack of assurance of product sterility. The affected lots were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug where sterility assurance cannot be verified. Although no illnesses have been reported, lack of sterility in injectable products creates a serious potential risk of infection. The product qualifies as a risk-of-harm product where injury has not yet been reported.
Plain-English summary
SCA Pharmaceuticals is recalling HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride injectable syringes (NDC 70004-0300-18) due to lack of assurance of sterility. The recall affects 1,425 syringes distributed nationwide in the USA.
The recalled product does not meet sterility assurance standards required for injectable medications. Injectable drugs must be sterile to prevent serious infections when administered to patients.
Affected lot numbers are: 1223048451 (Exp 11/20/23), 1223048923 (Exp 12/07/23), 1223049097 (Exp 12/15/23), and 1223049129 (Exp 12/19/23). Healthcare providers and pharmacies who have received these lots should stop dispensing them immediately. Patients who have received doses from recalled syringes should contact their healthcare provider.
The recalled product
- Product
- HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride, (Concentration = 0.2mg/ml) 30 mL Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-18, Bar Code 70004030018
- Manufacturer
- SCA Pharmaceuticals, LLC
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1223048451 Exp 11/20/23
- 1223048923 Exp 12/07/23
- 1223049097 Exp 12/15/23
- 1223049129 Exp 12/19/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27